全球癌症发病率不断增长，癌症已成为全球主要的公共问题。 36氪获悉，太盟投资集团（PAG）近日已完成对意大利新药研发企业NMS集团45%股权的收购，交易规模超14亿元。本次交易完成后，NMS集团将获得更为充沛的研发资金支持。 创立于1965年的NMS集团是一家知名 ...

意大利内尔维亚诺--(BUSINESS WIRE)--(美国商业资讯)--Nerviano Medical Sciences S.r.l. (NMS)是NMS集团下属成员公司，也是一家发现和开发癌症创新疗法的临床阶段公司。该公司今天宣布与Merck Healthcare KGaA签署了一项包含许可选择权的合作协议，以开发新一代高选择性和脑渗透 ...

经过四年的投后赋能加持，NMS集团已进入加速发展期。一村见证了NMS可喜的成绩，同时也帮助NMS集团建立起了与中国沟通与合作的桥梁。 2018年初，一村资本牵头组建中方联合并购方，完成对意大利老牌肿瘤研发机构NMS集团的控股型收购，该交易的总价值（包含 ...

Neuroleptic malignant syndrome (NMS) is a rare neurological condition associated with the use of antipsychotic medications. Autonomic dysfunction, or damage to the nerves that control involuntary ...

NEW YORK--(BUSINESS WIRE)--NMS Capital (“NMS”) announced today that it has partnered with Company management in the recapitalization of DirectMed Parts & Service, LLC (“DirectMed” or the “Company”).

Neuroleptic malignant syndrome (NMS) is a rare reaction to antipsychotic drugs that are used to treat schizophrenia, bipolar disorder, and other mental health conditions. It affects the nervous system ...

LOS ANGELES, CA / ACCESS Newswire / May 12, 2025 / NMS Capital Group ("NMS") is proud to announce its inclusion in the Los Angeles Business Journal's 2024 list of Top Private Equity Firms, published ...

New York, NY, October 22, 2019 – NMS Capital (“NMS”) announced today that it has exited its investment in ettain group, Inc. (“ettain” or the “Company”) through its sale to Alvarez & Marsal Capital ...